Previous studies have shown cellular insulin resistance in conventionally treated insulin-dependent diabetics. To determine whether insulin resistance is also present in insulin-dependent diabetics before the commencement of insulin therapy, we studied nine newly diagnosed untreated insulin-dependent diabetics and nine control subjects. Insulin binding to adipocytes, monocytes, and erythrocytes was normal in the diabetic individuals. Basal (noninsulin stimulated) glucose transport rate was normal, whereas the maximal insulin responsiveness of glucose transport was severely impaired (P < 0.02). Insulin sensitivity as judged by left or rightward shifts in the insulin dose-response curves was unchanged. Moreover, the basal lipogenesis rate measured at a glucose concentration of 0.5 mmol/liter was decreased in the diabetics (P < 0.05), and the maximal insulin responsiveness of lipogenesis was also reduced (P < 0.05).
Introduction
Insulin-dependent diabetes mellitus is caused primarily by the lack of or severely reduced production of insulin. However, recent in vivo studies have shown that insulin-dependent diabetic subjects display an impaired insulin effect on the disposal of glucose into peripheral tissues (1-7) as well as decreased inhibitory effect of insulin on hepatic glucose release (1, 5, 6) . In vitro studies have shown reduced insulin receptor binding in adipocytes from conventionally treated insulin-dependent diabetics (8, 9) . In agreement with the impaired insulin binding, doseresponse curves for the insulin effect on glucose transport (8) and antilipolysis (8, 9) were shifted to the right. However, no changes in insulin sensitivity were observed on glucose oxidation and glucose conversion to lipids (8) . Impaired basal and maximal insulin action on adipocyte glucose metabolism was found as well (8, 9) . It has been suggested that the insulin resistance of insulin-treated diabetic patients might be a result of the insulin treatment itself, and in particular the way of administration of insulin, namely subcutaneous injection, which causes high pe-ripheral levels of insulin as opposed to endogenously released insulin (8, 9) . Alternatively, the insulin resistance might be due to the metabolic decompensation of these patients.
The aim of the present study was to determine whether a state of cellular insulin resistance also exists in newly discovered, untreated patients with insulin-dependent diabetes. Hence, we have examined adipocyte insulin binding and action in young untreated insulin-dependent diabetics and in a comparable group of controls. Moreover, we have also measured insulin binding to erythrocytes and monocytes in order to make comparative studies on insulin binding to different cell types.
Methods
Subjects. Nine insulin-dependent diabetics were studied within the first 2 d of admission with newly diagnosed diabetes mellitus before the commencement of diet and insulin therapy. From the day of admission to the day of study, the patients ate the normal hospital diet for nondiabetic subjects (8 (14) and 10 mmol/liter in the studies of adipocyte insulin binding and action (11, 15 Insulin receptor binding to erythrocytes was determined as described (14) with the following modification. After fractionating the blood once on a Ficoll-Isopaque gradient, the erythrocytes were collected from the bottom of the tubes. The cells were resuspended 1:1 in 0.9% NaCl containing 50 mg/ml dextran 500 T. The tubes were tilted 450 from the vertical for 15 min at 370C. The Murphy (23) . C-peptide in serum was assayed by the method of Heding (24). Statistical methods. In the text and tables, data are given as mean± 1 SD while the data in the figures represent the mean± I SEM. An unpaired t test was used for comparison between groups. Linear regression analysis was employed in correlation studies using the least-squares method. Ketone bodies were log distributed and hence were log transformed before statistical analysis.
Results
The biochemical data of the patients and normal controls are given in Table I . All patients were nonobese. No significant difference in fat cell diameter was found. The fasting serum insulin levels ofdiabetics were only slightly decreased, whereas the basal as well as the glucagon-induced rise in serum C-peptide concentration was reduced in all patients, indicating insulin deficiency (10). As expected, the patients had significantly elevated fasting plasma concentration of ketone bodies (P < 0.001). However, none ofthe patients was acidotic. Fasting plasma concentrations of FFA were significantly increased in the diabetics (P < 0.05). Two patients had elevated urinary cortisol excretion (>385 mmol/liier), whereas only one had elevated fasting plasma growth hormone concentration (>6 Ag/ml). t P < 0.001. § P < 0.05. Fig. 1 depicts competition curves for insulin binding to fat cells measured at 37°C. When expressed in relation to cell surface area concentration, no significant difference between insulin binding to fat cells from normals and newly diagnosed insulindependent diabetics was observed. The same was the case when binding was expressed in relation to cell number concentration. Fat cell insulin binding measured at insulin tracer concentration at 15°C as well as insulin binding to erythrocytes and pure monocytes also measured at 15°C was similar in normals and diabetics (Table II) .
When adipocyte insulin binding was expressed in relation to cell surface area, no correlations between insulin binding to monocytes and adipocytes or monocytes and erythrocytes were found (Fig. 2) . However, a significant inverse correlation existed between erythrocytes and adipocytes (r = -0.70, P < 0.05, Fig.  2 The basal (noninsulin-stimulated) glucose transport rate into fat cells was identical in diabetics and normal controls (Fig. 3) . However, the insulin response above basal levels was severely reduced in fat cells from the diabetic patients as compared with normals (41±25% vs. 101±69%, P < 0.02). No difference in insulin sensitivity as expressed as left or rightward shifts in insulin dose-response curves was observed (ED50 was 58±25 pmol/liter in normals and 65±30 pmol/liter in the diabetic patients). In the diabetic patients, no correlation was found between percentage insulin response above the basal level ofglucose transport and fasting insulin levels (r = 0.05, NS), whereas plasma FFA concentrations correlated negatively to percentage insulin response (r = -0.72, P < 0.05). No correlations between degree of ketosis and glucose transport rates were found. In normal controls, no correlations between insulinemia or ketonemia or plasma FFA levels and glucose transport rates were observed. Glucose conversion to total lipids measured at a glucose concentration of 0.5 mmol/liter, where steps distal to glucose transport are rate limiting, is depicted in Fig. 4 . A significant decrease in noninsulin-stimulated lipogenesis was found in fat cells from the diabetic patients (P < 0.05). Moreover, the insulin response above basal levels was very low (35±23% vs. 72±41% in normals, P < 0.05). Actually, in two patients, no insulin response was detectable. The absolute lipogenesis rate in maximally insulin-stimulated cells was thus markedly reduced (to 40% of that in normals, Fig. 4 ). Due to the low insulin responses, changes in insulin sensitivity could not be estimated in these studies. No correlations between basal or maximally insulin-stimulated lipogenesis rates and fasting concentrations of insulin or ketone body or FFA were found in any of the groups.
Discussion
Normal insulin binding in patients with untreated insulin-dependent diabetes mellitus. The present study demonstrates that insulin binding to fat cells from insulin-requiring diabetics before the institution of insulin therapy is normal. The unaltered insulin binding in this study as opposed to the reduced binding in insulintreated diabetics (8, 9) supports the hypothesis that the reduced insulin binding in the latter studies is an acquired defect, probably secondary to subcutaneous insulin therapy, which causes high peripheral levels of insulin (8) . The insulin binding to erythrocytes and monocytes was also unaltered in the untreated, insulindependent diabetic patients corroborating previous studies (25 Recently, in a study of newly diagnosed noninsulin-dependent diabetics, we failed to find significant correlations between blood cells and fat cells (29 (37, 38) . Although our patients had significantly higher levels of ketone bodies than did normals, the absolute level of ketonemia was not high, and none of our patients was acidotic. No relationship between the levels of plasma ketones and insulin binding or action was observed.
Plasma counterregulatory hormones were also measured in order to evaluate their role in the event of insulin resistance (39) (40) (41) . However, only two of our patients had elevated urinary cortisol excretions, and one had elevated fasting plasma growth hormone concentrations. These patients were comparable to the rest of the group in all aspects. Therefore, it seems unlikely that the insulin unresponsiveness found in fat cells from our patients is caused primarily by these hormones. Catecholamines are also able to induce insulin resistance in vivo in man (42) and in vitro in isolated adipocytes (43). Actually, we did not measure serum catecholamines in our diabetics, but previous studies (44) have shown that the serum levels ofcatecholamines parallel the degree of metabolic derangement. Since none of our patients was acidotic or severely ketotic, it is unlikely that catecholamines were the major cause of insulin resistance in the diabetics for the present study.
Noninsulin-stimulated (basal) glucose transport and metabolism in fat cells from patients with insulin-dependent diabetes mellitus. No change in basal glucose transport rate in adipocytes from our diabetic patients was found, whereas basal glucose metabolism was severely depressed in the same cells. The interpretation of the depressed basal lipogenesis rate relative to the normal basal transport rate in fat cells from the untreated diabetics depends on whether transport or posttransport steps are regarded as being rate limiting for glucose metabolism. In our hands, transport is not rate limiting for basal glucose metabolism even in adipocytes from normal subjects (1 1).' This is discussed in detail elsewhere.' Shortly, it is based on the following observations: When medium glucose concentration is increased from tracer only (5 gmol/liter where transport is rate limiting [11, 18]) to 0.5 mmol/liter by addition of unlabeled glucose, the cellular uptake of radioactive glucose decreases to about one-third, whereas the transport rate is only slightly decreased (K. for glucose transport is 7 mmol/liter). The same decrease in cellular uptake is found if glucose is replaced by 2-deoxyglucose (which is phosphorylated but not further metabolized) at the same concentration, and/or 2-deoxyglucose is used as tracer. Thus, the decrease in cellular hexose uptake must be caused by competition at the level of phosphorylation and not by escape of transported glucose converted to metabolic products. Moreover, total lipids comprise >80% of the intracellular radioactivity at tracer concentration (1 1, 18) as well as at a glucose concentration of 0.5 mmol/liter (1 1)1 in human fat cells. The decreased basal lipogenesis rate in fat cells from untreated diabetics at this glucose concentration is therefore caused by a true decrease in metabolism rate and not by a shift in rate-limiting steps from transport to posttransport steps.
Although glucose conversion to total lipids is the most important metabolic pathway for glucose at this glucose concentration, other pathways such as lactate production may become ofrelative more importance at higher glucose concentrations ( 18) . The depressed basal rate of lipogenesis is not an insulin receptor or a postreceptor phenomenon, since it is present in cells not acutely exposed to insulin. Yet, the possibility exists that the impaired basal metabolic activity is a reflection ofthe insulindeficient state, especially the metabolic deterioration and catabolic changes that follow insulin deficiency. This interpretation agrees with the findings in insulin-deficient streptozotocin-treated rats (45) . Recently, however, it was shown that acute hyperinsulinism in normal subjects, induced by 6 h of insulin infusion, also leads to an impaired basal lipogenesis rate in adipocytes (46). Also, after chronic insulin therapy for several years, the basal glucose metabolism of fat cells from conventionally treated diabetics is severely depressed (8) . It has been hypothesized that this depression may be induced by the chronic peripheral hyperinsulinemia (8) . This idea is supported by studies ofthe longterm effects ofcontinuous insulin infusion therapy on adipocyte metabolism in insulin-dependent diabetics where a significant aggravation of basal glucose conversion to lipids has been found (47) . Thus, experimental evidence exists that suggests that both hypo-and hyperinsulinemia may induce impaired basal glucose metabolism in human adipocytes.
We conclude that in fat cells from untreated insulin-dependent diabetic subjects, insulin binding is normal, whereas the insulin responsiveness is markedly reduced at both glucose transport and glucose metabolism level. The basal glucose metabolism rate is also reduced. The observed abnormalities are most probably caused by insulin deficiency and accompanying catabolic deterioration.
